Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 3.36
(1.82%)
CNY 3.36
(1.82%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.84 Billion CNY | -4.8% |
| 2022 | 1.94 Billion CNY | -26.35% |
| 2021 | 2.63 Billion CNY | -2.6% |
| 2020 | 2.7 Billion CNY | 3.06% |
| 2019 | 2.62 Billion CNY | -6.47% |
| 2018 | 2.8 Billion CNY | -1.37% |
| 2017 | 2.84 Billion CNY | 0.96% |
| 2016 | 2.81 Billion CNY | 5.57% |
| 2015 | 2.67 Billion CNY | 3.27% |
| 2014 | 2.58 Billion CNY | 13.01% |
| 2013 | 2.28 Billion CNY | 24.66% |
| 2012 | 1.83 Billion CNY | 16.43% |
| 2011 | 1.57 Billion CNY | 39.25% |
| 2010 | 1.13 Billion CNY | 19.76% |
| 2009 | 945.24 Million CNY | 8.23% |
| 2008 | 873.35 Million CNY | 16.68% |
| 2007 | 748.52 Million CNY | 41.14% |
| 2006 | 530.33 Million CNY | 0.13% |
| 2005 | 529.66 Million CNY | 19.88% |
| 2004 | 441.83 Million CNY | 61.41% |
| 2003 | 273.72 Million CNY | 47.06% |
| 2002 | 186.13 Million CNY | 61.35% |
| 2001 | 115.35 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 359.44 Million CNY | 6.54% |
| 2024 Q3 | 336.41 Million CNY | -6.41% |
| 2024 Q1 | 337.38 Million CNY | -20.6% |
| 2023 Q1 | 465.04 Million CNY | 14.56% |
| 2023 Q3 | 454.94 Million CNY | -22.77% |
| 2023 Q2 | 589.04 Million CNY | 26.67% |
| 2023 FY | 1.84 Billion CNY | -4.8% |
| 2023 Q4 | 424.91 Million CNY | -6.6% |
| 2022 Q4 | 405.92 Million CNY | -13.31% |
| 2022 Q3 | 468.24 Million CNY | -17.02% |
| 2022 Q2 | 564.25 Million CNY | 12.26% |
| 2022 FY | 1.94 Billion CNY | -26.35% |
| 2022 Q1 | 502.61 Million CNY | -13.33% |
| 2021 Q2 | 675.94 Million CNY | 3.93% |
| 2021 Q1 | 650.39 Million CNY | -16.87% |
| 2021 FY | 2.63 Billion CNY | -2.6% |
| 2021 Q4 | 579.9 Million CNY | -20.5% |
| 2021 Q3 | 729.41 Million CNY | 7.91% |
| 2020 Q1 | 537.21 Million CNY | -22.95% |
| 2020 Q3 | 776.24 Million CNY | 27.25% |
| 2020 Q4 | 782.41 Million CNY | 0.8% |
| 2020 FY | 2.7 Billion CNY | 3.06% |
| 2020 Q2 | 610.01 Million CNY | 13.55% |
| 2019 Q4 | 697.26 Million CNY | -2.02% |
| 2019 Q1 | 631.6 Million CNY | -3.96% |
| 2019 Q3 | 711.62 Million CNY | 21.66% |
| 2019 FY | 2.62 Billion CNY | -6.47% |
| 2019 Q2 | 584.92 Million CNY | -7.39% |
| 2018 Q1 | 721.13 Million CNY | 1.34% |
| 2018 Q4 | 657.61 Million CNY | -13.59% |
| 2018 Q2 | 667.19 Million CNY | -7.48% |
| 2018 Q3 | 761.07 Million CNY | 14.07% |
| 2018 FY | 2.8 Billion CNY | -1.37% |
| 2017 Q4 | 711.57 Million CNY | 1.57% |
| 2017 FY | 2.84 Billion CNY | 0.96% |
| 2017 Q3 | 700.55 Million CNY | -7.06% |
| 2017 Q2 | 753.8 Million CNY | 10.82% |
| 2017 Q1 | 680.22 Million CNY | -2.91% |
| 2016 Q4 | 700.62 Million CNY | -5.73% |
| 2016 FY | 2.81 Billion CNY | 5.57% |
| 2016 Q1 | 595.27 Million CNY | -12.0% |
| 2016 Q3 | 743.17 Million CNY | -4.71% |
| 2016 Q2 | 779.93 Million CNY | 31.02% |
| 2015 Q1 | 536.34 Million CNY | -39.01% |
| 2015 FY | 2.67 Billion CNY | 3.27% |
| 2015 Q4 | 676.47 Million CNY | -6.67% |
| 2015 Q3 | 724.83 Million CNY | -1.06% |
| 2015 Q2 | 732.57 Million CNY | 36.59% |
| 2014 Q4 | 879.35 Million CNY | 28.03% |
| 2014 Q1 | 505.23 Million CNY | -40.61% |
| 2014 FY | 2.58 Billion CNY | 13.01% |
| 2014 Q2 | 514.34 Million CNY | 1.8% |
| 2014 Q3 | 686.81 Million CNY | 33.53% |
| 2013 FY | 2.28 Billion CNY | 24.66% |
| 2013 Q4 | 850.67 Million CNY | 41.51% |
| 2013 Q3 | 601.13 Million CNY | 40.15% |
| 2013 Q1 | 407.34 Million CNY | -35.16% |
| 2013 Q2 | 428.91 Million CNY | 5.29% |
| 2012 Q3 | 441.41 Million CNY | 3.18% |
| 2012 FY | 1.83 Billion CNY | 16.43% |
| 2012 Q1 | 337.94 Million CNY | -31.37% |
| 2012 Q2 | 427.81 Million CNY | 26.59% |
| 2012 Q4 | 628.23 Million CNY | 42.32% |
| 2011 Q1 | 300.14 Million CNY | -16.81% |
| 2011 Q3 | 405.07 Million CNY | 6.96% |
| 2011 Q4 | 492.43 Million CNY | 21.57% |
| 2011 Q2 | 378.69 Million CNY | 26.17% |
| 2011 FY | 1.57 Billion CNY | 39.25% |
| 2010 Q4 | 360.78 Million CNY | 18.78% |
| 2010 Q1 | 206.14 Million CNY | -26.58% |
| 2010 FY | 1.13 Billion CNY | 19.76% |
| 2010 Q2 | 261.39 Million CNY | 26.8% |
| 2010 Q3 | 303.73 Million CNY | 16.2% |
| 2009 Q4 | 280.76 Million CNY | 18.85% |
| 2009 Q3 | 236.23 Million CNY | 2.98% |
| 2009 Q2 | 229.4 Million CNY | 15.38% |
| 2009 Q1 | 198.83 Million CNY | -27.88% |
| 2009 FY | 945.24 Million CNY | 8.23% |
| 2008 Q4 | 275.7 Million CNY | 26.32% |
| 2008 FY | 873.35 Million CNY | 16.68% |
| 2008 Q1 | 185.68 Million CNY | -27.47% |
| 2008 Q2 | 193.7 Million CNY | 4.32% |
| 2008 Q3 | 218.25 Million CNY | 12.67% |
| 2007 Q1 | 130.06 Million CNY | -27.57% |
| 2007 Q2 | 189.6 Million CNY | 45.78% |
| 2007 FY | 748.52 Million CNY | 41.14% |
| 2007 Q4 | 256.01 Million CNY | 48.13% |
| 2007 Q3 | 172.83 Million CNY | -8.85% |
| 2006 Q2 | 125.02 Million CNY | 31.44% |
| 2006 Q1 | 95.12 Million CNY | -52.13% |
| 2006 Q4 | 179.58 Million CNY | 37.5% |
| 2006 Q3 | 130.6 Million CNY | 4.47% |
| 2006 FY | 530.33 Million CNY | 0.13% |
| 2005 Q4 | 198.71 Million CNY | 61.1% |
| 2005 FY | 529.66 Million CNY | 19.88% |
| 2005 Q1 | 88.79 Million CNY | -53.22% |
| 2005 Q2 | 118.8 Million CNY | 33.79% |
| 2005 Q3 | 123.34 Million CNY | 3.82% |
| 2004 Q1 | 77.36 Million CNY | 0.0% |
| 2004 Q3 | 84.3 Million CNY | -6.66% |
| 2004 Q2 | 90.32 Million CNY | 16.75% |
| 2004 FY | 441.83 Million CNY | 61.41% |
| 2004 Q4 | 189.83 Million CNY | 125.17% |
| 2003 FY | 273.72 Million CNY | 47.06% |
| 2002 FY | 186.13 Million CNY | 61.35% |
| 2001 FY | 115.35 Million CNY | 0.0% |